Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Completed NA INTERVENTIONAL NCT01976039

Rhinopharyngeal Retrograde Clearance is Effective to Adequate Upper Airways Function in Adults

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Professionals working in polluted areas may present increased clinical airways symptoms and dysfunction. Rhinopharyngeal retrograde clearance (RRC) has been used to improve mucus clearance in infants with bronchitis and bronchiolitis, and instillation the nasal cavity with saline has been used to reduce nasal inflammation in rhinitis and sinusopathies. The aim of this study was to assess the effects of RRC and RCC combined with saline (RRC+S) on nasal mucociliary clearance (MCC), mucus surface property, cellularity and airways symptoms in professional motorcyclists.

Detailed Description

Male motorcyclists (mean age 36 years) were recruited and randomly assigned to RRC or RRC+S. Subjects were assessed at baseline and 15 days after interventions for saccharin test, mucus contact angle, cellularity in nasal lavage and airways symptoms with the use of SNOT-20 questionnaire. Data were analyzed by two-way ANOVA for repeated measures with Bonferroni´s correction. A passive monitoring-system of nitrogen dioxide was used to assess the individual air pollution exposure along the study period. The association between nitrogen dioxide and the airways outcomes was analyzed by Spearman correlation test.

Interventions

Name: rhinopharyngeal retrograde clearance (RRC)
Type: OTHER
Description: The rhinopharyngeal retrograde clearance is a respiratory physical therapy technique that uses a forced inspiratory maneuver to clear the nasopharynx with the aid of saline instillation

Primary Outcomes

Measure: Saccharine transit time test (STT)
TimeFrame: 15 days
Description: To measure nasal mucociliary clearance. Subjects were asked to report the first perception of a sweet taste after 25 mg of saccharine powder was deposited in the free airflow nostril.

Trial Information

NCT ID

NCT01976039

Status

Completed

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

University of Sao Paulo

Last Updated

December 15, 2025